A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors

Background: The 2010 guidelines by ASCO-CAP have mandated that breast cancer specimens with ≥1% positively staining cells by immunohistochemistry should be considered Estrogen Receptor (ER) positive. This has led to a subclass of low-ER positive (1-10%) breast cancers. We have examined the biology a...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabhu, Jyothi S., Korlimarla, Aruna, Desai, Krisha, Alexander, Annie, Raghavan, Rohini, Anupama, CE, Dendukuri, Nandini, Manjunath, Suraj, Correa, Marjorrie, Raman, N, Kalamdani, Anjali, Prasad, MSN, Gopinath, K.S, Srinath, B.S., Sridhar, T.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930907/
https://www.ncbi.nlm.nih.gov/pubmed/24563670
http://dx.doi.org/10.7150/jca.7668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930907/
https://www.ncbi.nlm.nih.gov/pubmed/24563670
http://dx.doi.org/10.7150/jca.7668

Ejemplares similares